Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised
Antonio Jesús Banegas-Luna1, Jorge Peña-García1, Adrian Iftene2
1Structural Bioinformatics and High-Performance Computing Research Group (BIO-HPC), Universidad Católica de Murcia (UCAM), 30107 Murcia, Spain.
International Journal of Molecular Sciences
|April 30, 2021
Summary
Artificial intelligence (AI) and machine learning are revolutionizing cancer research. Improving model interpretability is crucial for integrating these AI tools into clinical practice for better cancer diagnosis and personalized therapies.
Area of Science:
- Medical Informatics
- Computational Biology
- Oncology
Background:
- Artificial Intelligence (AI), particularly machine learning (ML) and deep neural networks, is transforming medical applications.
- Cancer diagnosis and therapy are key areas benefiting from AI advancements.
- Current software tools require adaptation to meet the demands of AI integration in medicine.
Purpose of the Study:
- To survey current machine learning models and in-silico tools used in cancer research.
- To analyze the interpretability, performance, and input data of these AI models.
- To identify areas for improvement in AI for clinical practice.
Main Methods:
- Review of machine learning models including Artificial Neural Networks (ANN), Logistic Regression (LR), and Support Vector Machines (SVM).
- Analysis of Convolutional Neural Networks (CNNs) for image processing, leveraging Graphics Processing Units (GPUs) and High-Performance Computing (HPC).
- Evaluation of model interpretability, performance metrics, and data requirements.
Main Results:
- ANN, LR, and SVM are frequently used models in cancer research.
- CNNs are increasingly important for image-based cancer analysis.
- Model interpretability remains a significant challenge, hindering clinical trust and adoption.
Conclusions:
- Enhanced interpretability of AI models is essential for clinical decision-making.
- Improving AI interpretability will boost doctors' predictive capabilities.
- This advancement is key to achieving personalized cancer therapies in the future.
Related Concept Videos
Combination Therapies and Personalized Medicine
5.5K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.5K
Cancer Survival Analysis
497
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
497
Mouse Models of Cancer Study
6.0K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.0K
Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
Cancer
51.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.5K


